scispace - formally typeset
Journal ArticleDOI

Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.

TLDR
This study characterized the expression of Folh1 in theTRAMP model to determine if the TRAMP would be a useful model system to evaluate PSMA‐directed targeting strategies.
Abstract
BACKGROUND Prostate specific membrane antigen (PSMA) is expressed on the plasma membrane of normal prostate and in primary and metastatic prostate cancer in humans. Recently, a mouse homolog of PSMA (FOLH1) was identified that shares an 85% sequence homology with human PSMA. The transgenic adenocarcinoma of the mouse prostate (TRAMP) model displays spontaneous tumor development with age and metastasizes to tissues similar to human prostate cancer. This study characterized the expression of Folh1 in the TRAMP model to determine if the TRAMP would be a useful model system to evaluate PSMA-directed targeting strategies. METHODS A sensitive, real-time quantitative PCR assay was developed to measure Folh1 cRNA copy number in various tissues of 30–32-week-old TRAMP+ and age-matched, nontransgenic controls (TRAMP−). RESULTS Of the tissues studied, the highest expression of Folh1 was observed in the kidney and brain of both TRAMP+ and TRAMP− mice. Low levels of Folh1 cRNA (1–2 copies/ng total RNA) were detected in the tumor and lymph nodes of TRAMP + mice and in the seminal vesicles and lung of the TRAMP + and TRAMP− mice. The expression of Folh1 mRNA was sixfold higher in the prostate of 32-week-old TRAMP− mice compared to the tumor of 32-week-old TRAMP + mice. The rank order of the Folh1 expression in the tissues studied was kidney > brain > prostate > tumor > lymph nodes > lung > seminal vesicles > liver. Folh1 mRNA was undetectable in the bone marrow of both TRAMP+ and TRAMP− mice. Folate hydrolase activity assayed in the kidney, brain, lung, and liver paralleled the expression of Folh1 mRNA in these tissues. CONCLUSIONS We demonstrate that Folh1 is expressed at very high levels in some normal mouse tissues including the prostate gland and that the expression is not upregulated in the tumor of 32-week-old TRAMP + mice. Prostate 55: 308–316, 2003. © 2003 Wiley-Liss, Inc.

read more

Citations
More filters
Journal ArticleDOI

The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.

TL;DR: PSMA PET/CT is superior to morphological imaging for the detection of metastatic LNs in patients with primary prostate cancer and surgical dissection remains the gold standard for precise lymphatic staging.
Journal ArticleDOI

Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.

TL;DR: The search for an animal model in which to assess the efficacy and safety of anti‐PSMA monoclonal antibody (mAb)‐based therapies for prostate cancer or targeting tumor vasculature of various solid tumors is prompted.
Journal ArticleDOI

Molecular imaging of tumor angiogenesis.

TL;DR: Molecular imaging is a noninvasive approach to determine the expression of indicative marker molecules of the tumor angiogenesis process that has been established for all imaging modalities and may further improve sensitivity of diagnostic tumor imaging.
Journal ArticleDOI

Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors

TL;DR: The high tumor uptake achieved with these trifunctional ligands predicts larger doses delivered to the tumor than can be achieved with 177Lu-PSMA-617, and the exceptional area under the curve (AUC) in the tumor warrants further investigation of these novel ligands as candidates for RLT.
Journal ArticleDOI

Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human.

TL;DR: Intraprostatic PSMA targeted prodrugs/protoxins are under development in the laboratory and future toxicologic studies of these therapies require identification of animal models that express PSMA within the prostate.
References
More filters
Journal ArticleDOI

Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method

TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
Journal Article

Prostate-specific membrane antigen expression in normal and malignant human tissues.

TL;DR: The decrease in PSMA immunoreactivity noted in advanced prostate cancer suggests that expression of this molecule may be linked to the degree of tumor differentiation and the neoexpression of PSMA in endothelial cells of capillary beds in certain tumors may be related to tumor angiogenesis and suggests a potential mechanism for specific targeting of tumor neovasculature.
Journal ArticleDOI

Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR

TL;DR: Beta-2 microglobulin and 18S rRNA are suitable internal control genes in quantitative serum-stimulation studies, while beta-actin and GAPDH are not.
Journal ArticleDOI

3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures

TL;DR: MGB probes were more sequence specific than standard DNA probes, especially for single base mismatches at elevated hybridization temperatures, and fluorescence quenching was more efficient, giving increased sensitivity.
Journal Article

Five Different Anti-Prostate-specific Membrane Antigen (PSMA) Antibodies Confirm PSMA Expression in Tumor-associated Neovasculature

TL;DR: Prostate-specific membrane antigen (PSMA) was consistently expressed in the neovasculature of a wide variety of malignant neoplasms and may be an effective target for mAb-based antinesculature therapy.
Related Papers (5)